Targeting Inflammatory Signaling in Prostate Cancer Castration Resistance

Although castration-resistant prostate cancer (CRPC) as a whole, by its name, refers to the tumors that relapse and/or regrow independently of androgen after androgen deprivation therapy (ADT), untreated tumor, even in early-stage primary prostate cancer (PCa), contains androgen-independent (AI) PCa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Shangwei, Huang, Changhao, Chen, Zhikang, Chen, Zihua, Luo, Jun-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584457/
https://www.ncbi.nlm.nih.gov/pubmed/34768524
http://dx.doi.org/10.3390/jcm10215000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584457/
https://www.ncbi.nlm.nih.gov/pubmed/34768524
http://dx.doi.org/10.3390/jcm10215000

Ejemplares similares